LobbyingBiotechnology Innovation Organization lobbying by quarter
Biotechnology Innovation Organization's latest lobbying report covers Q2 2026, at $2.7M. The four quarters Q4 2025–Q3 2026 total $6.4M. Its first report covers Q4 2019; the issues it reports most are Health Issues and Trade (Domestic & Foreign).
Biotechnology Innovation Organization
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $6.4M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2019
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2019 | $3.1M | 1 |
| Q1 2020 | $0 | 0 |
| Q2 2020 | $0 | 0 |
| Q3 2020 | $0 | 0 |
| Q4 2020 | $0 | 0 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $0 | 0 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $4.1M | 7 |
| Q1 2023 | $2.7M | 7 |
| Q2 2023 | $2.5M | 7 |
| Q3 2023 | $2.5M | 7 |
| Q4 2023 | $2.5M | 7 |
| Q1 2024 | $2M | 6 |
| Q2 2024 | $2.1M | 6 |
| Q3 2024 | $1.9M | 6 |
| Q4 2024 | $1.7M | 6 |
| Q1 2025 | $1.1M | 5 |
| Q2 2025 | $2.1M | 7 |
| Q3 2025 | $1.7M | 7 |
| Q4 2025 | $1.8M | 6 |
| Q1 2026 | $1.9M | 6 |
| Q2 2026 | $2.7M | 6 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$4.9M · 85 reports
- Trade$2.9M · 39 reports
- Medicare and Medicaid$2.8M · 32 reports
- Budget and appropriations$2.7M · 30 reports
- Taxation$2.6M · 27 reports
- Medical research and clinical labs$2.5M · 21 reports
- Small business$2.5M · 18 reports
- Copyright, patent and trademark$2.4M · 17 reports
- Homeland security$2.4M · 16 reports
- Animals$1.7M · 14 reports
- Food industry$1.7M · 22 reports
- Agriculture$1.7M · 12 reports
- Chemicals$1.7M · 12 reports
- Energy and nuclear$1.7M · 12 reports
- Fuel, gas and oil$1.7M · 12 reports
- Science and technology$337.6K · 11 reports
- Consumer protection and safety$224.3K · 4 reports
- Pharmacy$75K · 5 reports
- Telecommunications$13.3K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE88 reports
- HOUSE OF REPRESENTATIVES86 reports
- Centers For Medicare and Medicaid Services (CMS)44 reports
- Health & Human Services, Dept of (HHS)34 reports
- Commerce, Dept of (DOC)24 reports
- U.S. Trade Representative (USTR)20 reports
- White House Office19 reports
- Food & Drug Administration (FDA)17 reports
- Natl Security Council (NSC)16 reports
- Patent & Trademark Office (PTO)16 reports
- State, Dept of (DOS)16 reports
- Executive Office of the President (EOP)14 reports
- Office of Management & Budget (OMB)12 reports
- Agriculture, Dept of (USDA)11 reports
- Treasury, Dept of11 reports
- Natl Economic Council (NEC)10 reports
- Environmental Protection Agency (EPA)8 reports
- Natl Institutes of Health (NIH)7 reports
- Securities & Exchange Commission (SEC)6 reports
- Justice, Dept of (DOJ)5 reports
- Office of Science & Technology Policy (OSTP)5 reports
- Federal Trade Commission (FTC)4 reports
- Small Business Administration (SBA)3 reports
- Council of Economic Advisers (CEA)2 reports
- Office of the Vice President of the United States2 reports
- U.S. International Trade Commission (ITC)2 reports
- Centers For Disease Control & Prevention (CDC)1 reports
- Energy, Dept of1 reports
- U.S. Fish & Wildlife Service (USFWS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBiotechnology Innovation Organization | $32.2M | 16 quarters |
| Avoq | $1.2M | 15 quarters |
| Akin Gump Strauss Hauer & Feld | $960K | 15 quarters |
| BGR Government Affairs | $900K | 15 quarters |
| Todd Strategy Group | $540K | 9 quarters |
| Dla Piper | $300K | 5 quarters |
| Valcour | $220K | 5 quarters |
| SL Strategies | $200K | 5 quarters |
| Arentfox Schiff | $20K | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q2 2026 |
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q2 2026 |
| DAN GREENWOOD | Deputy Asst. to the President for Leg Affairs; Sr. Dir. for Leg. Affairs National Security Council; Dir. USMC Cong. Liaison (House); USMC Officer | Q2 2026 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q2 2026 |
| DON ANDRES | COS, Rep Norma Torres; COS, LD, Rep Jesus Chuy Garcia; Sr Pol Adv, Rep Steve Cohen; Sr. LA / Sh Cmte Staff, Rep Eddie Bernice Johnson; LA, LC, Sch, Sp Asst., Rep Steven Horsford; Staff Asst H Dem Caucus; Intern, Reps Berman, Hahn, Bass | Q2 2026 |
| JAMES WILLIAMS | Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors, 2017-2019 | Q2 2026 |
| JENNIFER BROWN | Bnk. Coun. Ldr. Schumer; Tax Coun. Sen. Menendez; Econ. Coun. House Sm. Biz. Cmt.; ERISA Specialist U.S. DOL | Q2 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| MARA LEFEVRE | Leg. Asst., Sen. Hoeven (2025-2026); Leg. Aide, Sen. Hoeven (2025); Leg. Cor., Sen. Hoeven (2023-2024); Staff Asst., Sen. Hoeven (2022-2023); Intern, Sen. KCramer (2020). | Q2 2026 |
| RAGHAV AGGARWAL | Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q2 2026 |
| STEVEN PFRANG | COS, Rep. LaHood; Dep COS, LD, Rep. Reed; LA, LC, SA, Intern, Rep. Fossella | Q2 2026 |
| RACHEL PORTMAN | Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman | Q1 2026 |
| BLAKE CENTER | Intern, Sen. Bob Corker; Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Marsha Blackburn; Legislative Assistant, Rep. Kevin McCarthy; Legislative Assistant, 20thDistrict of California; Legislative Assistant, Rep. Vince Fong | Q2 2025 |
| DAVID SCHWIETERT | Sen. Comm. On Commerce, Science, & Transport., Staff Dir (13-15); Sen. Thune, Leg. Dir (07-12); Sen. Comm. On Environ. & Public Works, Waste Management SubComm., Staff Dir (05-06). | Q2 2025 |
| LINDSEY SEIDMAN | R Clerk - Sen Approps LHHS Subcmte (Sen. Capito); R Dep Staff Dir - Sen HELP Cmte (Sen. Burr); R Dep Staff Dir/Sr Policy Adv - Sen HELP Cmte (Sen. Alexander); Professional Staff - Sen Rules Cmte (Sen. Alexander); LA/Corr Dir/LC -Sen. Alexander | Q2 2025 |
| MATTHEW MOWERS | US Department of State - Senior White House Advisor | Q2 2025 |
| WILLIAM KENNETH KILLION | US Department of State - Director of House Affairs, Intergovernmental Affairs and Special Advisor for Oversight; Acting Director, Regional, Global, and Functional Affairs; Special Assistant for Intergovernmental and Legislative Affairs | Q2 2025 |
| ZACHARY PAULSEN | Intl. Trade Policy Asst., U.S. Sen. Committee on Finance, 2002-05. | Q2 2025 |
| RYAN LONG | Senior Policy and Counsel, Speaker Kevin McCarthy; Senior Policy Advisor and Counsel, Minority Leader Kevin McCarthy; Deputy Staff Director and Staff Director, House Energy and Commerce Committee; LC, Rep Norwood; LA & LD, Rep Barton | Q1 2025 |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid | Q4 2024 |
| ERIC BERGREN | Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker | Q4 2024 |
| JEFF LUCAS | Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon | Q4 2024 |
| KATHERINE FLEMING COTTON | Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie | Q4 2024 |
| KIMBERLY LINTHICUM | Legislative Director, Representative Bob Franks; Legislative Correspondent, Representative Charles Taylor; Legislative Correspondent, Representative Bill Martini | Q4 2024 |
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg | Q4 2024 |
| TAYLOR SEXTON | Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess | Q4 2024 |
| TED LEHMAN | Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant | Q4 2024 |
| NICHOLAS UEHLECKE | Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee | Q2 2024 |
| RICHARD COPPOLA | Intern, Rep. Himes (Aug 17 - Dec 17); Intern, Sen. Blumenthal (Jan 18 - Mar 18) | Q1 2024 |
| SARA LOVE RAWLINGS | U.S. Senate Committee on Appropriations | Q4 2023 |
| VIRGIL MILLER | Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19. | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $2.4M |
| 07/20for Q2 | Avoq | $80K |
| 07/20for Q2 | BGR Government Affairs | $60K |
| 07/20for Q2 | Valcour | $50K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | $60K |
| 07/17for Q2 | Dla Piper | $60K |
| 04/20for Q1 | Avoq | $80K |
| 04/20for Q1 | Valcour | $50K |
| 04/20for Q1 | In-house | $1.6M |
| 04/20for Q1 | BGR Government Affairs | $60K |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | $60K |
| 04/20for Q1 | Dla Piper | $60K |
| 01/20for Q4 2025 | Avoq | $80K |
| 01/20for Q4 2025 | In-house | $1.5M |
| 01/20for Q4 2025 | Valcour | $50K |
| 01/20for Q4 2025 | BGR Government Affairs | $60K |
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | $60K |
| 01/16for Q4 2025 | Dla Piper | $60K |
| 25/10/20for Q3 2025 | Avoq | $80K |
| 25/10/20for Q3 2025 | In-house | $1.4M |